Skip to main content
. 2003 Sep;133(3):461–466. doi: 10.1046/j.1365-2249.2003.02239.x

Table 1.

Patient characteristics

Treatments

Patient Age (years) Sex Platelets (×109/l) Months since diagnosis Months since splenectomy Prior Current
Responders
  1 61 F 198  24  22 Pr, IVIg None
  2 31 F 383 201 177 Pr, IVIg None
  3 47 M  64 142  23 Pr, IVIg, dan, anti-D, CSA, Vcr None
  4 33 F 399 202 198 Pr, IVIg None
  5 22 F 209  95  83 Pr, IVIg, MPr None
  6 35 F 331 226 213 Pr, IVIg, anti-D None
Non-responders
  7 29 F  13  56  44 Pr, IVIg IVIg
  8 53 F  21 225 211 Pr, IVIg, Vcr None
  9 43 F   7 187 178 Pr, IVIg, dan, CSA, Vcr Pr
 10 38 F   6  10   7 Pr, IVIg, dan, anti-D, Vcr, cytox IVIg
 11 34 F  13  52  48 Pr, IVIg, dan, anti-D, Vcr IVIg
 12 54 F   5  58  55 Pr, IVIg, dan, anti-D, Vcr IVIg

Pr = prednisone; IVIg = intravenous immune globulin; dan = danazol; CSA = cyclosporine; Vcr = vincristine; cytox = oral cyclophosphamide; MPr = methylprednisolone.